Evidence map›Paper›PMID 29296931›Full record

ArticleBlood advances2017

Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study.

Sigrun Thorsteinsdottir, Sigrun H Lund, Ebba K Lindqvist, Marianna Thordardottir, Gunnar Sigurdsson, Rene Costello, Debra Burton, Hlif Steingrimsdottir, Vilmundur Gudnason, Gudny Eiriksdottir and 4 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 34 citations in OpenAlex.

  1. Monoclonal Gammopathy of Thrombotic Significance.American journal of hematology · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Hematological Diseases and Osteoporosis.International journal of molecular sciences · 2020
    Review
  10. MGUS bone.Oxford medical case reports · 2019
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Advanced Imaging of Multiple Myeloma Bone Disease.Frontiers in endocrinology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Sigrun ThorsteinsdottirDepartment of Internal Medicine, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
Sigrun H LundFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Ebba K LindqvistDivision of Hematology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
Marianna ThordardottirFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Gunnar SigurdssonIcelandic Heart Association, Kopavogur, Iceland.
Rene CostelloCenter for Cancer Research, National Cancer Institute, and.
Debra BurtonCenter for Cancer Research, National Cancer Institute, and.
Hlif SteingrimsdottirDepartment of Internal Medicine, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
Vilmundur GudnasonFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Gudny EiriksdottirIcelandic Heart Association, Kopavogur, Iceland.
Kristin SiggeirsdottirIcelandic Heart Association, Kopavogur, Iceland.
Tamara B HarrisNational Institute on Aging, National Institutes of Health, Bethesda, MD; and.
Ola LandgrenMyeloma Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Sigurdur Y KristinssonDepartment of Internal Medicine, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
Icelandic Heart Association · ISUniversity of Iceland · ISCancer Institute (WIA) · INNational University Hospital of Iceland · ISKarolinska Institutet · SEMemorial Sloan Kettering Cancer Center · USNational Institutes of Health · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Age, Gene/environment Susceptibility Study In Iceland - Ocular ComponentZIAEY000401 · NEI · NATIONAL EYE INSTITUTE · PI COTCH, MARY FRANCES · 2009 to 2020
$3.3M
AGES STUDY-THE REYKJAVIK STUDY OF HEALTHY AGING FOR THE NEW MILLENNIUM-26012100N01AG012100 · NIA · ICELANDIC HEART ASSOCIATION · 2002 to 2004
–
Intramural NIH HHS ZIA EY000401NCI NIH HHS P30 CA008748NIA NIH HHS N01 AG012100
6 · The paper itself

Abstract

Previous studies have shown that individuals with monoclonal gammopathy of undetermined significance (MGUS) have an increased risk of fractures, although the underlying mechanisms remain unknown. Our aim was to analyze bone mineral density (BMD), bone volume, and risk of fractures among individuals with MGUS. We performed a screening using the Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study cohort, consisting of 5764 elderly individuals, identifying 300 individuals with MGUS, and 275 with light-chain MGUS. Quantitative computerized tomography was performed in the lumbar spine and hip to evaluate BMD and bone geometry. Analysis of variance and the Tukey honest significance test were used to compare the groups. Hospital records were used to record fractures, with a mean follow-up of 6.9 years. Cox proportional hazard was used to compare fracture risk. No difference was found in BMD between subjects with MGUS and others in the spine (

Identifiers

PMID29296931
PMCPMC5745135
OpenAlexW2776907385

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.